Literature DB >> 22986169

Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3.

J R Paul1, R L Johnson, R S Jope, K L Gamble.   

Abstract

Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in psychiatric diseases, neurodevelopment, and circadian regulation. Both GSK3 isoforms, α and β, exhibit a 24-h variation of inhibitory phosphorylation within the suprachiasmatic nucleus (SCN), the primary circadian pacemaker. We examined the hypothesis that rhythmic GSK3 activity is critical for robust circadian rhythmicity using GSK3α(21A/21A)/β(9A/9A) knock-in mice with serine-alanine substitutions at the inhibitory phosphorylation sites, making both forms constitutively active. We monitored wheel-running locomotor activity of GSK3 knock-in mice and used loose-patch electrophysiology to examine the effect of chronic GSK3 activity on circadian behavior and SCN neuronal activity. Double transgenic GSK3α/β knock-in mice exhibit disrupted behavioral rhythmicity, including significantly decreased rhythmic amplitude, lengthened active period, and increased activity bouts per day. This behavioral disruption was dependent on chronic activation of both GSK3 isoforms and was not seen in single transgenic GSK3α or GSK3β knock-in mice. Underlying the behavioral changes, SCN neurons from double transgenic GSK3α/β knock-in mice exhibited significantly higher spike rates during the subjective night compared to those from wild-type controls, with no differences detected during the subjective day. These results suggest that constitutive activation of GSK3 results in the loss of the typical day/night variation of SCN neuronal activity. Together, these results implicate GSK3 activity as a critical regulator of circadian behavior and neurophysiological rhythms. Because GSK3 has been implicated in numerous pathologies, understanding how GSK3 modulates circadian rhythms and neurophysiological activity may lead to novel therapeutics for pathological disorders and circadian rhythm dysfunction.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986169      PMCID: PMC3490018          DOI: 10.1016/j.neuroscience.2012.08.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock.

Authors:  S Martinek; S Inonog; A S Manoukian; M W Young
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

Review 2.  Circadian rhythms from multiple oscillators: lessons from diverse organisms.

Authors:  Deborah Bell-Pedersen; Vincent M Cassone; David J Earnest; Susan S Golden; Paul E Hardin; Terry L Thomas; Mark J Zoran
Journal:  Nat Rev Genet       Date:  2005-07       Impact factor: 53.242

Review 3.  Post-translational modifications regulate the ticking of the circadian clock.

Authors:  Monica Gallego; David M Virshup
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

4.  Age-related decline in circadian output.

Authors:  Takahiro J Nakamura; Wataru Nakamura; Shin Yamazaki; Takashi Kudo; Tamara Cutler; Christopher S Colwell; Gene D Block
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

5.  Differential effect of lithium on the circadian oscillator in young and old hamsters.

Authors:  Eiko Iwahana; Toshiyuki Hamada; Ayumi Uchida; Shigenobu Shibata
Journal:  Biochem Biophys Res Commun       Date:  2007-01-18       Impact factor: 3.575

6.  Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus.

Authors:  S T Inouye; H Kawamura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3.

Authors:  Jing Wei; Wenhua Liu; Zhen Yan
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

8.  Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.

Authors:  Richard Scott Jope
Journal:  Front Mol Neurosci       Date:  2011-08-09       Impact factor: 5.639

9.  Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Front Mol Neurosci       Date:  2011-10-24       Impact factor: 5.639

10.  GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration.

Authors:  Raquel Gómez-Sintes; Félix Hernández; José J Lucas; Jesús Avila
Journal:  Front Mol Neurosci       Date:  2011-11-16       Impact factor: 5.639

View more
  21 in total

1.  Circadian rhythmicity of active GSK3 isoforms modulates molecular clock gene rhythms in the suprachiasmatic nucleus.

Authors:  Rachel C Besing; Jodi R Paul; Lauren M Hablitz; Courtney O Rogers; Russell L Johnson; Martin E Young; Karen L Gamble
Journal:  J Biol Rhythms       Date:  2015-02-27       Impact factor: 3.182

2.  Glycogen synthase kinase 3 regulates photic signaling in the suprachiasmatic nucleus.

Authors:  Jodi R Paul; Alex S McKeown; Jennifer A Davis; Stacie K Totsch; Eric M Mintz; Timothy W Kraft; Rita M Cowell; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2017-03-21       Impact factor: 3.386

3.  Akt1 Controls the Timing and Amplitude of Vascular Circadian Gene Expression.

Authors:  Amelia K Luciano; Jeans M Santana; Heino Velazquez; William C Sessa
Journal:  J Biol Rhythms       Date:  2017-04-28       Impact factor: 3.182

4.  Circadian disruption of hippocampus in an early senescence male mouse model.

Authors:  Jennifer A Davis; Jodi R Paul; Mugdha V Mokashi; Stefani A Yates; Daniel J Mount; Hira A Munir; Lacy K Goode; Martin E Young; David B Allison; Karen L Gamble
Journal:  Pharmacol Biochem Behav       Date:  2022-04-18       Impact factor: 3.697

5.  Ras Activity Oscillates in the Mouse Suprachiasmatic Nucleus and Modulates Circadian Clock Dynamics.

Authors:  Tsvetan Serchov; Antje Jilg; Christian T Wolf; Ina Radtke; Jörg H Stehle; Rolf Heumann
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

6.  Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.

Authors:  Jodi R Paul; Hira A Munir; Thomas van Groen; Karen L Gamble
Journal:  Neurobiol Dis       Date:  2018-03-11       Impact factor: 5.996

Review 7.  Metabolism as an integral cog in the mammalian circadian clockwork.

Authors:  Karen L Gamble; Martin E Young
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-17       Impact factor: 8.250

8.  Synchronized time-keeping is key to healthy mood regulation (Commentary on Landgraf et al.).

Authors:  Jennifer A Davis; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2016-01-13       Impact factor: 3.386

9.  GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity.

Authors:  Rachel C Besing; Courtney O Rogers; Jodi R Paul; Lauren M Hablitz; Russell L Johnson; Lori L McMahon; Karen L Gamble
Journal:  Hippocampus       Date:  2017-05-27       Impact factor: 3.899

10.  The GSK-3β-FBXL21 Axis Contributes to Circadian TCAP Degradation and Skeletal Muscle Function.

Authors:  Marvin Wirianto; Jiah Yang; Eunju Kim; Song Gao; Keshav Raj Paudel; Jong Min Choi; Jeehwan Choe; Gabrielle F Gloston; Precious Ademoji; Randika Parakramaweera; Jianping Jin; Karyn A Esser; Sung Yun Jung; Yong-Jian Geng; Hyun Kyoung Lee; Zheng Chen; Seung-Hee Yoo
Journal:  Cell Rep       Date:  2020-09-15       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.